Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient
A technology of dihydronaphthalene derivatives and dihydronaphthalene, which can be applied in the directions of organic active ingredients, medical preparations containing active ingredients, drug combinations, etc., and can solve rare problems and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
reference example 1
[0328] 3-(5-Hydroxy-3,4-dihydronaphthalen-1-yl)propionic acid
[0329]
[0330] To pyridine hydrochloride (200 g) was added 3-(5-methoxy-3,4-dihydronaphthalen-1-yl)propionic acid (25.1 g; known compounds (see J.Chem.Soc.Perkin Trans.I., 1739-1742 (1987)), then stirred at 180°C for 3 hours. The reaction mixture was cooled to room temperature and diluted with water. The aqueous layer was acidified with concentrated hydrochloric acid. The aqueous layer was extracted with ethyl acetate. Extract with saturated aqueous sodium bicarbonate solution. The combined aqueous layers were acidified with concentrated hydrochloric acid, and then extracted with ethyl acetate. The combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the title compound (11.8g), which has the following physical data.
[0331] TLC: Rf0.42 (chloroform: methanol = 6: 1);
[0332] NMR (CDCl 3 ): δ9.21(s, 1H), 6.98(dd, J=7...
reference example 2
[0334] Methyl 3-(5-hydroxy-3,4-dihydronaphthalen-1-yl)propionate
[0335]
[0336] Anhydrous methanol (40 ml) was cooled to -10°C, and thionyl chloride (5.92 ml) was added dropwise thereto under an argon atmosphere, followed by stirring at -10°C for 20 minutes. To this solution, the compound (11.8 g) prepared in Reference Example 1 was added, followed by stirring at room temperature for 1 hour. The reaction mixture was concentrated under reduced pressure, then azeotroped with toluene (twice). The residue was purified by silica gel column chromatography (chloroform to chloroform:methanol=50:1) to obtain the title compound (10.6 g) having the following physical data.
[0337] TLC: Rf0.72 (chloroform:methanol=10:1);
[0338] NMR (CDCl 3 ): δ7.06(dd, J=7.8, 7.6Hz, 1H), 6.88(d, J=7.6Hz, 1H), 6.70(d, J=7.8Hz, 1H), 5.88(t, J=4.4Hz , 1H), 4.93(s, 1H), 3.68(s, 3H), 2.82-2.62(m, 4H), 2.58-2.49(m, 2H), 2.26(m, 2H).
reference example 3
[0340] 5-Pivaloyloxy-1,2,3,4-tetralin-1-one
[0341]
[0342] To a solution of pyridine (180 ml) in 5-hydroxy-1-tetralone (30.0 g), 4-dimethylaminopyridine (1.13 g) was added, and pivaloyl chloride (25.0 ml) was added thereto under ice cooling , and then stirred overnight at room temperature. The reaction mixture was ice-cooled, and concentrated hydrochloric acid was added thereto, followed by extraction with ethyl acetate. The extract was washed successively with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=9:1~5:1) to obtain the title compound (45.4 g) having the following physical data.
[0343] TLC: Rf 0.42 (hexane: ethyl acetate = 5: 1);
[0344] NMR (CDCl 3 ): δ7.95(dd, J=7.8, 1.4Hz, 1H), 7.33(t, J=7.8Hz, 1H), 7.19(dd, J=7.8, 1.4Hz, 1H), 2.79(t, J= 6.0Hz, 2H), 2.65(dd, J=7.6, 6.0Hz, 2H), 2.19-2.05(m, 2H), 1.40(s, 9H).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com